CompletedNot applicableNCT03235427
Official study title

The CAROLE (CArdiac Related Oncologic Late Effects) Study

Study summary

CAROLE seeks to evaluate the relationship between chest Radiation Therapy and coronary artery disease. The purpose of CAROLE is to check the heart health of women who received breast cancer treatments in the past and protect them from future heart disease.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forCoronary Artery Disease · Cardiac Disease

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 21, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Northwell Health

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Northwell Health
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • If you are a breast cancer survivor who was diagnosed between the ages of ≥ 18-65 years (now at age 26-78).
  • It has been at least 6 years since you were diagnosed.
  • If you did not have a diagnosis of heart disease before\
  • having breast cancer.
  • (\*women diagnosed with heart disease after breast cancer may still be eligible)
Reasons someone may not be able to joinExclusion criteria
  • Patients who are unable to care for themselves or who are unable to come in for testing due to health conditions or incarceration will be rescheduled or removed in the case of chronic ineligibility. No vulnerable patient populations will be used in this study. Patients will be excluded if they have any pre-existing cardiac disease at the time of diagnosis of their breast cancer (2004-2011).
  • Pregnant and nursing women are ineligible.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Northwell HealthLake Success, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 21, 2019. Always confirm current availability with the study team.

View original record ↗